Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 SEK | +1.21% | +1.21% | +19.71% |
Evolution of the average Target Price on Egetis Therapeutics AB
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock
- Equities
- Stock Egetis Therapeutics AB - Nasdaq Stockholm
- Consensus Egetis Therapeutics AB